Results 1 to 10 of about 67,342 (249)

Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. [PDF]

Int J Mol Sci, 2023
Tribukait B, Lundgren PO, Kjellman A, Norming U, Nyman CR, Jagarlmundi K, Gustafsson O.   +6 more
europepmc   +1 more source

Green silver nanoparticles of Khaya senegalensis as dual inhibitors of viral thymidine kinase and 3 C protease: metabolomics, and computational insights. [PDF]

Sci Rep
El Gizawy HA, El-Aleam RHA, Hassan NH.
europepmc   +1 more source

Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer. [PDF]

Prostate, 2022
Lundgren PO, Tribukait B, Kjellman A, Norming U, Jagarlmudi K, Gustafsson O.   +5 more
europepmc   +1 more source

Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients. [PDF]

Front Oncol
Li P, Cheng Y, Zhao J, Fang Y, Zhao T.
europepmc   +1 more source

Association of thymidine kinase-1 with prostate cancer

Asian Journal of Surgery
Changyi Jiang, Wenting Zhou, Linhui Wang, Changxing Ke   +3 more
doaj   +1 more source

Vitamin D attenuates the progression of pulmonary fibrosis via inhibiting thymidine kinase 1/PFKFB3-driven glycolysis. [PDF]

J Transl Med
Yang H, Zhang L, Han M, Zhu K, Guo X, Yang W, Xu Q.   +6 more
europepmc   +1 more source

Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors. [PDF]

Immunooncol Technol
Egyhazi Brage S, Costa Svedman F, Bergqvist M, Helgadottir H.   +3 more
europepmc   +1 more source

Evaluation of thymidine kinase 1 and folate receptor alpha as potential biomarkers in prostate cancer. [PDF]

Sci Rep
Ahmed SI, Mohy AM, Farid HM, Elnaggar GN.   +3 more
europepmc   +1 more source

The critical role of serum thymidine kinase 1(STK1) in predicting prognosis for immunotherapy in T4 stage lung squamous cell carcinoma. [PDF]

Heliyon, 2023
Pan J, Liu H, Li S, Wei W, Mai J, Bian Y, Ning S, Li J, Zhang L.   +8 more
europepmc   +1 more source

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors. [PDF]

Breast Cancer Res Treat
Brown NL, Howell SJ, Papantoniou D, Eriksson O, Bergqvist M, Williams A, Kavanagh A, Backlund A, Albu-Kareem A, Elinder E, Larsson K, Uminska M, Ekholm M.   +12 more
europepmc   +1 more source